Dysplasia severity, but not experiences during colposcopy, predicts adherence to follow-up colposcopy

Psycho-Oncology

Volumn 21, Issue 3, 2012, Pages 291-296

  Kola, Susanna ^a   Walsh, Jane C ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

adherence; anxiety; cervical cancer; colposcopy; oncology; pain perception

Indexed keywords

ADULT; ANXIETY; ARTICLE; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIENCE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOCICEPTION; PAIN; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; STATE TRAIT ANXIETY INVENTORY; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA;

ADULT; ANXIETY; COLPOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; PAIN; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UTERINE CERVICAL DYSPLASIA;

EID: 84858018707     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1895     Document Type: Article

References (39)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
2. Altekruse SF, Kosary CL, Krapcho M, et al,. SEER cancer statistics review, 1975-2007. Journal [serial on the Internet]. Date; based on November 2009 SEER data submission, posted to the SEER web site, 2010 (Available from:).
3. Marcus AC, Crane LA, Kaplan CP, et al,. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care 1992; 30 (3): 216-230.
4. Lerman C, Hanjani P, Caputo C, et al,. Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol 1992; 10 (2): 330-333.
5. Radecki Breitkopf C, Catero J, Jaccard J, Berenson AB,. Psychological and sociocultural perspectives on follow-up of abnormal Papanicolaou results. Obstet Gynecol 2004; 104: 1347-1354. (Pubitemid 40458734)
6. Khanna N, Phillips MD,. Adherence to care plan in women with abnormal Papanicolaou smears: a review of barriers and interventions. J Am Board Fam Pract 2001; 14 (2): 123-130. (Pubitemid 33705687)
7. Engelstad LP, Stewart SL, Nguyen BH, et al,. Abnormal Pap smear follow-up in a high-risk population. Cancer Epidemiol Biomarkers Prev 2001; 10: 1015-1020. (Pubitemid 32959147)
8. Leyden WA, Manos MM, Geiger AM, et al,. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 2005; 97: 675-683. (Pubitemid 40812631)
9. Sanders G, Craddock C, Wagstaff I,. Factors influencing default at a hospital colposcopy clinic. Qual Health Care 1992; 1: 236-240.
10. Kola S, Walsh JC,. Patients' psychological reactions to colposcopy and LLETZ treatment for further evaluation of cervical intraepithelial neoplasia. Eur J Obstet Gynecol Rep Biol 2009; 146: 96-99.
11. Juraskova I, Butow P, Sharpe L, Campion M,. 'What does it mean?' Uncertainty, trust and communication following treatment for pre-cancerous cervical abnormalities. Psycho-Oncology 2007; 16 (6): 525-533. (Pubitemid 47039553)
12. Fang CY, Miller SM, Mills M, et al,. The effects of avoidance on cytotoxic/suppressor T cells in women with cervical lesions. Psycho-Oncology 2003; 12: 590-598. (Pubitemid 37086734)
13. Fang CY, Miller SM, Bovbjerg DH, et al,. Perceived stress is associated with impaired T-cell response to HPV16 in women with cervical dysplasia. Ann Behav Med 2008; 35: 87-96.
14. Lester H, Wilson S,. Is default from colposcopy a problem, and if so what can we do? A systematic review of the literature. Br J Gen Pract 1999; 49 (440): 223-229. (Pubitemid 29119101)
15. Abercrombie PD,. Improving adherence to abnormal Pap smear follow-up. J Obstet Gynecol Neonatal Nurs 2001; 30 (1): 80-88.
16. Eggleston KS, Coker AL, Prabhu Das I, Cordray ST, Luchok KJ,. Understanding barriers for adherence to follow-up care for abnormal Pap tests. J Women's Health 2007; 16 (3): 311-330. (Pubitemid 46668913)
17. Balasubramani L, Orbell S, Hagger M, Brown V, Tidy J,. Can default rates in colposcopy really be reduced? Int J Obstet Gynaecol 2008; 115: 403-408.
18. Orbell S, Hagger M, Brown V, Tidy J,. Comparing two theories of health behavior: a prospective study of noncompletion of treatment following cervical cancer screening. Health Psychol 2006; 25 (5): 604-615. (Pubitemid 44600922)
19. Orbell S, Hagger M,. 'When no means no:' can reactance augment the theory of planned behavior? Health Psychol 2006; 25 (5): 586-594. (Pubitemid 44600920)
20. Marcus AC, Kaplan CP, Crane LA, et al,. Reducing loss-to-follow-up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow-up protocol and economic incentives. Med Care 1998; 36 (3): 397-410. (Pubitemid 128456382)
21. Spielberger CB, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA,. State-Trait Anxiety Inventory. Consulting Psychologists Press: Palo Alto, 1983.
22. Price DD, Riley III JL, Wade JB,. Psychophysical approaches to measurement of the dimensions and stages of pain In: Handbook of Pain Assessment (2nd edn), Turk DC, Melzack R, (eds). Guildford Press: New York, 2001; 53-75.
23. Jensen MP, Karoly P., Self-report scales and procedures for assessing pain in adults. In: Handbook of Pain Assessment, Turk DC, Melzack R, (eds). Guildford: New York, 2001; 15-34.
24. Jensen MP, Karoly P, Braver S,. The measurement of clinical pain intensity: a comparison of six methods. Pain 1986; 27: 117-126. (Pubitemid 16003213)
25. Melzack R,. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1: 277-299.
26. Melzack R, Katz J., The McGill Pain Questionnaire: appraisal and current status. In: Handbook of Pain Assessment (2nd edn), Turk DC, Melzack R, (eds). Guildford: New York, 2001; 35-52.
27. Eger RR, Peipert JE,. Risk factors for noncompliance in a colposcopy clinic. J Reprod Med 1996; 41 (9): 671-674. (Pubitemid 26313930)
28. Fox P, Arnsberger P, Zhang X,. An examination of differential follow-up rates in cervical cancer screening. J Community Health 1997; 22 (3): 199-209.
29. Paskett ED, Phillips KC, Miller ME,. Improving compliance among women with abnormal Papanicolaou smears. Obstet Gynecol 1995; 86: 353-359.
30. Massad LS, Meyer PM,. Predicting compliance with follow-up recommendations after colposcopy among indigent urban women. Obstet Gynecol 1999; 94 (3): 371-376. (Pubitemid 29393072)
31. Hartz LE, Fenaughty AM,. Management choice and adherence to follow-up after colposcopy in women with cervical intraepithelial neoplasia 1. Obstet Gynecol 2001; 98 (4): 674-679. (Pubitemid 32907466)
32. Radecki Breitkopf C, Pearson HC,. A theory-based approach to understanding follow-up of abnormal Pap tests. J Health Psychol 2009; 14 (3): 361-371.
33. Bornstein J, Bahat-Sterensus H,. Predictive factors for noncompliance with follow-up among women treated for cervical intraepithelial neoplasia. Gynecol Obstet Investig 2004; 58 (4): 202-206. (Pubitemid 39482657)
34. Quinlivan JA, Petersen RW, Gani L, Tan J,. Demographic variables routinely collected at colposcopic examination do not predict who will default from conservative management of cervical intraepithelial neoplasia I. Aust N Z J Obstet Gynaecol 2005; 45 (1): 48-51. (Pubitemid 40424715)
35. Usha Kiran TS, Jayawickrama NS,. Who are the women who default from colposcopy clinics? J Obstet Gynaecol 2002; 22 (5): 537-539. (Pubitemid 35222870)
36. Kavanagh AM, Simpson JM,. Predicting nonattendance for colposcopy clinic follow-up after referral for an abnormal Pap smear. Aust N Z J Public Health 1996; 20 (3): 266-271. (Pubitemid 26318590)
37. Kinlen LJ, Spriggs AI,. Women with positive cervical smears but without surgical intervention: a follow-up study. Lancet 1978; 312 (8087): 463.
38. Andrae B, Kemetli L, Sparen P, et al,. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008; 100: 622-629.
39. Le T, Hopkins L, Menard C, Hicks-Boucher W, Lefebvre J, Fung Kee Fung M,. Psychologic morbidities prior to loop electrosurgical excision procedure in the treatment of cervical intraepithelial neoplasia. Int J Gynecol Cancer 2006; 16 (3): 1089-1093. (Pubitemid 43886731)